Dementia Drugs Market 2023 : Expected to Witness Substantial Expansion : CAGR of 8.5% from 2022 to 2031, Report
Allied Market Research published a report, titled, "Dementia Drugs Market by Indication (Lewy Body Dementia, Parkinsons Disease Dementia, Alzheimers Disease, Vascular Dementia, Other Indications), by Drug Class (Cholinesterase Inhibitors, NMDA Antagonists and its Combination Drugs), by Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies): Global Opportunity Analysis and Industry Forecast, 2021-2031".According to the report, the global dementia drugs industry generated $8.7 billion in 2021, and is anticipated to generate $19.7 billion by 2031, witnessing a CAGR of 8.5% from 2022 to 2031.
๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐จ๐ฉ๐ฒ ๐จ๐ ๐๐๐ฉ๐จ๐ซ๐ญ - https://www.alliedmarketresearch.com/request-sample/12379
๐๐ซ๐ข๐ฆ๐ ๐๐๐ญ๐๐ซ๐ฆ๐ข๐ง๐๐ง๐ญ๐ฌ ๐จ๐ ๐ ๐ซ๐จ๐ฐ๐ญ๐ก
Increase in the prevalence of Alzheimer's disease, advancement in R&D activities for drug development, rise in the adoption of early diagnosis, the growing geriatric population, increase in investment in R&D by players, presence of robust pipeline candidates, increase in public awareness about the disease prevention in developing regions, and the surge in demand for personalized medicines drive the growth of the global dementia drugs market. However, strict government regulations related to product approval and high cost linked to R&D activity restrain the growth of dementia drugs industry. Conversely, accelerated technological advancement in drug discovery techniques and high investment for drug development by the government are expected to offer lucrative opportunity for the dementia drugs market in future.
๐๐จ๐ฏ๐ข๐-19 ๐๐๐๐ง๐๐ซ๐ข๐จ
The outbreak of the Covid-19 pandemic had a positive impact on the global dementia drugs market, as it was reported that the pandemic caused a significant rise in the number of dementia patients.
Some research has shown that the COVID-19 infection can increase a person's likelihood of developing dementia and cause the symptoms to show up earlier.
Moreover, COVID-19 shows adverse impact on brain function by reducing the level of consciousness. Thus, increase in COVID-19 infection in patients with Alzheimer's disease increased the demand for dementia drugs during the pandemic.
๐๐ก๐ ๐๐ฅ๐ณ๐ก๐๐ข๐ฆ๐๐ซ'๐ฌ ๐๐ข๐ฌ๐๐๐ฌ๐ ๐ฌ๐๐ ๐ฆ๐๐ง๐ญ ๐ญ๐จ ๐ฆ๐๐ข๐ง๐ญ๐๐ข๐ง ๐ข๐ญ๐ฌ ๐ฅ๐๐๐๐๐ซ๐ฌ๐ก๐ข๐ฉ ๐ฌ๐ญ๐๐ญ๐ฎ๐ฌ ๐ญ๐ก๐ซ๐จ๐ฎ๐ ๐ก๐จ๐ฎ๐ญ ๐ญ๐ก๐ ๐๐จ๐ซ๐๐๐๐ฌ๐ญ ๐ฉ๐๐ซ๐ข๐จ๐
Based on indication, the Alzheimer's disease segment held the highest market share in 2021, accounting for around three-fifths of the global dementia drugs market, and is estimated to maintain its leadership status throughout the forecast period. This is owing to the increase in life expectancy, rise in ageing population, and changes in lifestyle. However, the vascular dementia segment is projected to manifest the highest CAGR of 10.0% from 2022 to 2031, owing to an increasing number of people, especially geriatrics and smokers, with high risk of developing vascular dementia as well as increasing understanding of diagnosis modalities.
๐๐ก๐ ๐๐ก๐จ๐ฅ๐ข๐ง๐๐ฌ๐ญ๐๐ซ๐๐ฌ๐ ๐ข๐ง๐ก๐ข๐๐ข๐ญ๐จ๐ซ๐ฌ ๐ฌ๐๐ ๐ฆ๐๐ง๐ญ ๐ญ๐จ ๐ฆ๐๐ข๐ง๐ญ๐๐ข๐ง ๐ข๐ญ๐ฌ ๐ฅ๐๐๐๐๐ซ๐ฌ๐ก๐ข๐ฉ ๐ฌ๐ญ๐๐ญ๐ฎ๐ฌ ๐ญ๐ก๐ซ๐จ๐ฎ๐ ๐ก๐จ๐ฎ๐ญ ๐ญ๐ก๐ ๐๐จ๐ซ๐๐๐๐ฌ๐ญ ๐ฉ๐๐ซ๐ข๐จ๐
Based on drug class, the cholinesterase inhibitors segment held the highest market share in 2021, accounting for nearly two-thirds of the global dementia drugs market, and is estimated to maintain its leadership status throughout the forecast period, owing to increase in the geriatric population, rise in the prevalence of dementia, and growth in drug discovery. However, the NMDA antagonists and its combination drugs segment is projected to manifest the highest CAGR of 9.2% from 2022 to 2031, owing to a rise in the prevalence of neurological disorders, robust R&D by key players toward the disease treatment, and increased hospitalization rate.
๐ ๐จ๐ซ ๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐๐ง๐ช๐ฎ๐ข๐ซ๐ฒ- https://www.alliedmarketresearch.com/purchase-enquiry/12379
๐๐ก๐ ๐ก๐จ๐ฌ๐ฉ๐ข๐ญ๐๐ฅ ๐ฉ๐ก๐๐ซ๐ฆ๐๐๐ข๐๐ฌ ๐ฌ๐๐ ๐ฆ๐๐ง๐ญ ๐ญ๐จ ๐ฆ๐๐ข๐ง๐ญ๐๐ข๐ง ๐ข๐ญ๐ฌ ๐ฅ๐๐๐ ๐ฉ๐จ๐ฌ๐ข๐ญ๐ข๐จ๐ง ๐๐ฎ๐ซ๐ข๐ง๐ ๐ญ๐ก๐ ๐๐จ๐ซ๐๐๐๐ฌ๐ญ ๐ฉ๐๐ซ๐ข๐จ๐
Based on distribution channel, the hospital pharmacies segment accounted for the largest share in 2021, contributing to nearly half of the global dementia drugs market, and is projected to maintain its lead position during the forecast period. This is owing to the increase in geriatric population and Alzheimer's patients. However, the online pharmacies segment is expected to portray the largest CAGR of 11.1% from 2022 to 2031, owing to the convenience and cheaper costs of purchasing prescription drugs electronically, especially under the lockdown situation during the COVID-19 pandemic.
๐๐จ๐ซ๐ญ๐ก ๐๐ฆ๐๐ซ๐ข๐๐ ๐ญ๐จ ๐ฆ๐๐ข๐ง๐ญ๐๐ข๐ง ๐ข๐ญ๐ฌ ๐๐จ๐ฆ๐ข๐ง๐๐ง๐๐ ๐๐ฒ 2031
Based on region, North America held the highest market share in terms of revenue in 2021, accounting for more than two-fifths of the global dementia drugs market, and is likely to dominate the market during the forecast period, owing to the increase in R&D investments by numerous companies in the region. However, the Asia-Pacific region is expected to witness the fastest CAGR of 10.6% from 2022 to 2031.
Increase in spending capabilities, owing to the evolving healthcare regulatory landscape, increase in the number of patients with chronic diseases, and the government's emphasis on enhancing R&D capabilities for innovative drug development in the region.
๐๐๐๐๐ข๐ง๐ ๐๐๐ซ๐ค๐๐ญ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ: -
Apotex inc.
Aurobindo Pharma Ltd.
Biogen Idec
Eisai
Eli Lilly and Company
Johnson & Johnson
Abbvie Inc.
F. Hoffmann-La Roche AG
Teva Pharmaceutical Industries
Novartis AG
๐๐ง๐จ๐ฐ ๐๐จ๐ซ๐ https://www.alliedmarketresearch.com/dementia-drugs-market-A12014
๐๐ข๐ฆ๐ข๐ฅ๐๐ซ ๐๐๐ฌ๐๐๐ซ๐๐ก ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ ๐๐จ๐ซ ๐๐ข๐๐ ๐๐๐ข๐๐ง๐๐ ๐๐จ๐ฆ๐๐ข๐ง
๐๐๐ฉ๐ญ๐ข๐๐ ๐๐ก๐๐ซ๐๐ฉ๐๐ฎ๐ญ๐ข๐๐ฌ ๐๐๐ซ๐ค๐๐ญ https://www.alliedmarketresearch.com/peptide-therapeutics-market-A11226
๐๐จ๐๐ฒ ๐ ๐๐ญ ๐๐๐๐ฎ๐๐ญ๐ข๐จ๐ง ๐๐๐ซ๐ค๐๐ญ https://www.alliedmarketresearch.com/body-fat-reduction-market-A10916
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Follow Us on: LinkedIn Twitter
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Dementia Drugs Market 2023 : Expected to Witness Substantial Expansion : CAGR of 8.5% from 2022 to 2031, Report here
News-ID: 3336384 • Views: โฆ
More Releases from Allied Market Research
Wet Chemicals Market Navigating Potential Future Market Size as a Compass to Suc โฆ
According to the report published by Allied Market Research, the global wet chemicals market was valued at $3.2 billion in 2021 and is projected to reach $5.9 billion by 2031, with a compound annual growth rate (CAGR) of 6.3% from 2022 to 2031. The comprehensive report offers a detailed analysis of key investment opportunities, top strategies for success, market drivers, opportunities, market size and forecasts, competitive landscape, and emerging marketโฆ
Growlers Market Size Worth USD 791.1 million By 2031 | Growth Rate (CAGR) of 5.4 โฆ
The Growlers Market Size was valued at $456.8 million in 2021, and is projected to reach $791.1 million by 2031, growing at a CAGR of 5.4% from 2022 to 2031. A growler is a draught beer container made of glass, ceramic, or stainless steel that is mostly used in the United States, Canada, Australia, Brazil, and other nations. Breweries and brewpubs frequently sell them to customers who want to purchaseโฆ
Polyaspartic Coatings Market Trend is Growing Worldwide with Future Opportunitie โฆ
According to the report published by Allied Market Research, the global polyaspartic coating market was estimated at $347.6 million in 2021 and is expected to hit $515.1 million by 2031, registering a CAGR of 4.0% from 2022 to 2031. The report provides a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and evolving market trends. The market study isโฆ
Aviation Gasoline Market Growth, Competitive Analysis, Prospects, And Top Key Pl โฆ
The aviation gasoline market is characterized by a delicate balance between technological innovation, regulatory compliance, and market demand. As aircraft manufacturers continue to develop more efficient and environmentally friendly piston engines, the demand for advanced formulations of avgas evolves accordingly. Moreover, stringent safety and quality standards imposed by aviation authorities worldwide shape the production, distribution, and usage of avgas.
The global aviation gasoline (avgas) market size was valued at $12.5 billionโฆ
More Releases for Dementia
Dementia Care APP Market Is Booming Worldwide 2021-2027 | Dementia Digital Diary โฆ
Global Dementia Care APP market 2020-2026 in-depth study accumulated to supply latest insights concerning acute options. The report contains different predictions associated with Dementia Care APP market size, revenue, production, CAGR, consumption, profit margin, price, and different substantial factors. Whereas accentuation the key driving and Dementia Care APP restraining forces for this market, the report offers trends and developments. It additionally examines the role of the leadingโฆ
Dementia screening and prevention โ hope or hype?
It is estimated that about 50% of dementia patients do not receive a formal diagnosis. And when the diagnosis is made, it often happens at a time when the disease is well advanced and brain damages are irreversible.
A major reason for this is that systematic dementia screening and prevention programmes are not yet ready for implementation as large-scale public health interventions. A key reason for this is the desireโฆ
Dementia Treatment
Dementia Drugs and Treatment Market describes its growth, size, share, Forecast and trends to 2025
The global Dementia Drugs and Treatment market is valued at 13900 million US$ in 2018 is expected to reach 26500 million US$ by the end of 2025, growing at a CAGR of 8.4% during 2019-2025.
This report focuses on Dementia Drugs volume and value at global level, regional level and company level. From a global perspective, thisโฆ
New App detects dementia risks early
โข The App is certified as a Medical Device.
โข Early stages are reliably detected, before the brain damage becomes irreversible.
โข Sensitivity above 96%, significantly higher than with the established tests (e.g., MMSE 71%).
โข Now available for free during pre-launch.
Dementia is a rapidly increasing social problem of a rapidly aging society. Because until today there is no effective therapy for advanced stages of dementia.
Therefore, effective screening tests are needed to detect early stagesโฆ
2nd International Conference on Dementia and Dementia Care
Breakthrough in Dementia Research and Care
Event Name: 2nd International Conference on Dementia and Dementia Care (Dementia 2019)
Theme: Breakthrough in Dementia Research and Care
Aim and Scope: Dementia is an umbrella term used to describe a set of symptoms that occur when the brain is affected by disease. Thereโs currently no cure and no treatment that slows or stops its progression, but there are things you can do to help reduce theโฆ
11th International Conference on Vascular Dementia
Can We Cure Dementia, Vascular Dementia and Alzheimer's disease?
Itโs our pleasure to invite all the participants from all over the world to attend the 11th International Conference on Vascular Dementia which is held during February 15-16, 2019 Amsterdam| Netherlands.
Vascular Dementia conference will assemble illustrious speakers, Researchers, Nobel laureates, Neurologists, and Neuroscience researchers from both academic and health care professionals will join this event to discuss their views and research. Theโฆ